I accumulated this one since 2018 before the name and ticker change, being under water for many months. This ticker has come a long way. It intended to get into vaping business and had an opportunity to work with the biggest tobacco company, but the bad media exposure killed the momentum. Since the pandemic company switched its attention to COVID-19 by delivering nicotine to lung through vaping. They intended to start animal study in India. I knew it was a long shot, there is no way for them to reach any results without spending millions and before COVID concedes.
This German Fintech company came to the rescue at the right moment. This one could reach $5-10 in near term in my opinion.
The float is very tiny based on the trading volume, so wild fluctuations of share price is expected on the way to multiple dollars.
News 
Market Data 
Discover 
